User login
Enter your username and password here in order to log in on the website:
Keywords
- ABPA_Aspergillus
- accompanying diseases
- air-improving devices
- allergy
- animals_pets
- antibiotic therapy
- asthma
- complementary medicine
- covid-19
- diabetes
- diagnostics
- drugs side effects
- drugs under development_genetic therapy
- ENT
- general aspects
- genetics
- health care
- hepatobiliary disease
- hygiene
- i.v.-lines
- inhalation
- lung
- microbiology
- miscellaneous
- modulator therapy
- MRSA
- nutrition and GI problems
- oxygen supplementation_therapy
- physiotherapy
- Pseudomonas aeruginosa
- psychosocial
- public facilities
- recreational activities
- reproduction
- research
- social law
- sport
- swine flu_novel influenza
- transplantation
- travelling
- vaccination
- ventilation
Topics
- VX-770
- Hello, The VX770 molecule (Ivacaftor) acts on the G551D mutation and, also, positively effects on 9 other class 3 mutations. Which ones? Thank you for your response.
- 28.02.2012
- vertex 770 and r347p
- Dear team, my daugther CF has got mutation r347p (class IV). I red that vertex 770 could work on r117h (class IV too). Is the defect of conductance caused by r347p similat to the defect caused by r117h? Is it probable that vertex 770 can work also for r347p? In case it works for r117h, will it ...
- 28.02.2012
- Question #1: Is it PTC 124? / Question #2: Amendment to my question
- [Note from ECORN-CF: This combines two questions the questioner asked consecutively.] Dear expert team, I have three important questions: 1) My doctor, who unfortunately is not there anymore now, had me examined in order to find out which mutation I have. I do not remember the name now; ...
- 28.02.2012
- VX770 - Kalydeco
- The child in question has G551 and F508 Delta mutations. For us VX770 provides great hope and just pray soon such a drug will be available to all other CF patients. I have read as much as possible on this drug but do not see information that I would wish to know. As a person with one faulty ...
- 27.02.2012
- VX-770
- Hi there, My daughter is currently 7 months old with G551D as one of her mutations. I just wondered if the drug is approved this year in the 6yrs and older subset can it then be used in younger children with the dosage ammended accordingly? Or would they need to carry out a clinical trial in ...
- 23.01.2012
- What is afoot?
- vx-770, vx 809-miglustat, ptc124, DNAase, all these are related to CF, but how are things coming along? What are all these? How has the financial crisis these last two years affected the research? Is gene therapy still being researched, or has it been abandoned? Would it be possible to make custom ...
- 23.01.2012
- Gene therapy for CF
- I would like to ask the experts about the course of the research in relation to the gene therapy of CF that takes place in the UK and USA and if there is ground to hope for a medical breakthrough.
- 23.01.2012
- VX770
- I know although VX770 is probably soon to be licensed it is still very early days. However, what I have read is that this should considerable help a CF patient with G551 gene. PRESUMING this medication opens the 'gate' it is said that although not a cure this should control CF in the same way that ...
- 16.01.2012
- new inhalative treatment
- Hello my daughter's doctor told her that a new aerosol would be placed on the market in early 2012. Can you tell me a little more? Is it an antibiotic, a mucolytic, ..... Thank you in advance for your reply.
- 02.01.2012
- advanced research
- hello, I wanted to find out the research against cystic fibrosis, which projects could emerge soon? and then at what stage is gene therapy? thank you
- 02.01.2012
